Lynparza and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lynparza (olaparib) and Lantus (insulin glargine recombinant). Common drug interactions include nausea among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Lynparza and Lantus. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Lynparza?

Lynparza has active ingredients of olaparib. eHealthMe is studying from 12,322 Lynparza users. Check the latest studies of Lynparza.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Jul, 04, 2026

26 people who take Lynparza and Lantus together, and have interactions are studied.

What are the common drug interactions of Lynparza and Lantus, by gender? *:

female:

Nausea (feeling of having an urge to vomit)
Vomiting
Drug ineffective
Headache (pain in head)
Diarrhoea
Bladder neoplasm (bladder tumour)
Cerebrovascular disorder (disease of brain)
Constipation
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

male:

Drug ineffective
Chest discomfort
Fatigue (feeling of tiredness)
Headache (pain in head)
Influenza
Malignant neoplasm progression (cancer tumour came back)
Pain
Pulmonary oedema (fluid accumulation in the lungs)
Pyrexia (fever)
Red blood cell count decreased

What are the common drug interactions of Lynparza and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Confusional state
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Pulmonary thrombosis (scarring in the lungs)
Thrombosis (formation of a blood clot inside a blood vessel)

50-59:

Abdominal distension
Constipation
Nausea (feeling of having an urge to vomit)
Oedema peripheral (superficial swelling)
Vomiting
Diarrhoea

60+:

Drug ineffective
Nausea (feeling of having an urge to vomit)
Renal failure (kidney dysfunction)
Sluggishness (lacking alertness)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Vomiting
Diarrhoea
Chills (felling of cold)
Death
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 7 people, 26.92%
Prostate Cancer: 5 people, 19.23%
Type 1 Diabetes: 2 people, 7.69%
Pancreatic Carcinoma (pancreatic cancer): 2 people, 7.69%
Ovarian Cancer Recurrent (reoccurrence of ovary cancer): 2 people, 7.69%
Insomnia (sleeplessness): 2 people, 7.69%
High Blood Cholesterol: 2 people, 7.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 7.69%
Dry Eyes (lack of adequate tears): 2 people, 7.69%
Breast Cancer Female: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Lynparza and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously